This is a study registration for a Phase 2 platform trial that is actively recruiting with no results posted; it describes planned design and endpoints only.
Reported
Planned enrollment900
Study phasePhase 2
Age range50–80 years
Clinical trial
1 development in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
This is a study registration for a Phase 2 platform trial that is actively recruiting with no results posted; it describes planned design and endpoints only.